Skip to content

TO COMPARE THE EFFECT OF TWO AYURVEDA MEDICINE IN MANAGEMENT OF INFANTILE COLIC

A COMPARATIVE STUDY TO EVALUATE THE EFFECT OF VACHADI ARKA AND SUPACHAYA ARKA IN THE MANAGEMENT OF UDARASHOOLA (INFANTILE COLIC) IN INFANTS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028643
Enrollment
50
Registered
2020-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Vachadi Arka: 0.5ml of Vachadi arka will be given 8th hourly with equal water to 25 patient Control Intervention1: Supachaya Arka: 0.5ml of Supachaya arka will be given 8th hourly with

Sponsors

Sri Dharmasthala Manjunatheswara college of ayurveda and hospital Hassan Thannirhallah Hassan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Infants of either gender with infantile colic between the age group 1 to 4 months . • All the babies who are breast feeding . • Infants whose parents has agreed to participate their child in the study. • Parents willing to give written consent .

Exclusion criteria

Exclusion criteria: Known cases of congenital anomalies. Infants with known cases of chromosomal, metabolic and hereditary disorder. Infants with any other systemic disorder. Infant on formula and cow milk feeding. Diarrhoea ,vomiting or any GIT condition to be excluded.

Design outcomes

Primary

MeasureTime frame
Pain,vomiting,cry will reduce sleep duration will increaseTimepoint: 0th day 7th day

Secondary

MeasureTime frame
proper weight gain in infantsTimepoint: 1 month

Countries

India

Contacts

Public ContactDr Shailaja U

Sri Dharmasthala Manjunatheswara college of ayurveda and hospital, Hassan

rao.shaila@gmail.com9448816433

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026